The results come as Pfizer and other drugmakers grapple with Trump’s calls to lower U.S. drug prices and brace for his planned tariffs on pharmaceuticals.
Recent Posts
- HDFC Bank Shares In Focus: HSBC Cuts Target Price, Says Atanu’s Exit An ‘Overhang’— Should You Buy, Sell, Or Hold?
- Kalyan Jewellers Stock to Buy? Motilal Oswal Sees Favorable Risk-Reward — Check Target Price, Upside
- Avendus Spark Initiates ‘Buy’ On Dr Agarwal’s Health Care, Sees Growth Prospects
- Sai Parenteral’s IPO: From GMP to key dates, price band, peers and more – 10 key things to know before subscribing
- HDFC Bank share price extends losses for fourth straight session. Time for bottom-fishing?